A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study. (Q35782691)
Jump to navigation
Jump to search
scientific article published on 22 November 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study. |
scientific article published on 22 November 2011 |
Statements
A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study (English)
Joseph Chao
Robert J Morgan
Charles Kunos
Dean Lim
Stephen Shibata
Vincent Chung
Ronald G Stoller
Mark McNamara
Barbara J Gitlitz
Derick H Lau
Suresh S Ramalingam
Angela Davies
Igor Espinoza-Delgado
Edward M Newman
Yun Yen
David R Gandara
22 November 2011
1 reference
1 reference
1 reference